EFFICIENCY OF THE DRUG "NAZOFERON" FOR TREATMENT OF INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN
DOI:
https://doi.org/10.54890/.v2i2.552Abstract
Summary: In this work clinical study of Nazoferon drug (nasal drops) was done. There were two groups, consisting of 80 children aged from 1 month to 6 years with a clinical diagnosis of acute respiratory viral infections (ARI). The children were with severe form of disease and they were treated at the Republic clinical infectious hospital. Of these, 40 patients treated with Nazoferon, this main group, the other 40 patients whodid not receive the drug were in the control group. According to severity of 47.5% of patients in the control group were treated in the intensive care unit. The superinfection was in 40.0% of patients from the control group. The duration of fever was 1,4 ± 0,3; 4,2 ± 1,0 days. Length of hospital stay was 3,0 ± 0,1; 5,2 ± 1,0 days. The duration of antibiotic therapy was 3,0 ± 1,0; 9,8 ± 3,0 days and the duration of infusion therapy was 1,4 ± 0,3;. 4,2 ± 1,0 days. The difference in these groups has been identified (P <0,05).
Keywords:
children, acute respiratory viral infections,References
1. Кузнецова М.А. Современные средства профилактики и лечения острых респираторных вирусных инфекций у детей (обзор) [Текст] / М.А.Кузнецова // Саратовский научно-медицинский журнал. – 2012. - Т. 8. - № 3. - С. 803–812.
2. Учайкин В.Ф. Руководство по инфекционным болезням у детей [Текст] / В.Ф. Учайкин. - Москва, 2008. – 162 с.
3. Лиманская Ю.А. Препараты интерферона в лечении острых респираторных вирусных инфекций у беременных группы высокого риска [Текст] / Ю.А. Лиманская, Ю.В. Давыдова // Здоровье женщины. – 2015.- № 9 (105). - С. 44-46.